- Research article
- Open Access
- Open Peer Review
Antibacterial, anti-HIV-1 protease and cytotoxic activities of aqueous ethanolic extracts from Combretum adenogonium Steud. Ex A. Rich (Combretaceae)
BMC Complementary and Alternative Medicine volume 12, Article number: 163 (2012)
Records have shown that Combretum adenogonium Steud. Ex A. Rich (Combretaceae) is used in traditional medicine systems of several tribes in Tanzania. This study focused on the investigation of antibacterial activity, anti-HIV-1 protease activity, toxicity properties and classes of phytochemicals in extracts from C. adenogonium Steud. Ex A. Rich (Combretaceae) to evaluate potential of these extracts for development as herbal remedies.
Dried plant material were ground to fine powder and extracted using 80% aqueous ethanol to afford root, leaf and stem bark extracts. The extracts were assayed for anti-HIV-1 protease activities, antibacterial activities using microdilution methods and cytotoxicity using brine shrimps lethality assay. Screening for major phytochemical classes was carried out using standard chemical tests.
All extracts exhibited antibacterial activity to at least one of the test bacteria with MIC-values ranging from 0.31-5.0 mg/ml. Two extracts, namely, root and stem bark exhibited anti-HIV-1 PR activity with IC50 values of 24.7 and 26.5 μg/ml, respectively. Stem bark and leaf extracts showed mild toxicity with LC50 values of 65.768 μg/ml and 76.965 μg/ml, respectively, whereas roots were relatively non-toxic (LC50 = 110.042 μg/ml). Phytochemical screening of the extracts indicated presence of flavonoids, terpenoids, alkaloids, tannins, glycosides and saponins.
These results provide promising baseline information for the potential development of C. adenogonium extracts in treatment of bacterial and HIV/AIDS-related opportunistic infections.
The escalating number of HIV/AIDS cases in sub-Saharan African countries has dramatically raised high demand for medical care in health facilities throughout this resource-poor region. Treatment of HIV/AIDS is limited due to unavailability and high costs of antiretroviral drugs (ARVs) together with limited infrastructure for monitoring of HIV/AIDS patients. Phytomedicines have shown great promise in the treatment of infectious diseases including AIDS-related opportunistic infections. Records indicate that the majority of traditional healers in Eastern, Southern and Western Africa use Combretaceae species for treatment of conditions like abdominal disorders, backache, bilharzia, cancer, coughs, colds, conjunctivitis, diarrhea, dysentery, dysmenorrhoea, fever, gastric ulcers, general weakness, venereal diseases, headaches, heart diseases, hypertension, jaundice, leprosy, nosebleeds, oedema, pneumonia, skin diseases, sore throats, dental caries, diabetes, enteralgia, eye diseases, general fatigue, hiccups, loss of appetite, malaria, menorrhagia, tuberculosis, tumours, HIV/AIDS infections, wasting and yellow fever[2–5]. Plants of the Combretum and Terminalia genera constitute majority of the Combretaceae family that are widely represented in Tanzania. At least 55 and 17 species of Combretum and Terminalia, respectively, are reported to be growing in Tanzania ranging from climbers, shrubs and big trees. Most of these species are also found in other parts of tropical and warm temperate regions of the world[5, 6]. Combretum adenogonium Steud. Ex A. Rich (Combretaceae) (syn:Combretum fragrans F. Hoffm or Combretum ghasalense Engl. & Diels) is a shrub or a small tree which grows up to 10-12 m high. It is common in deciduous woodland (Miombo) and wooded grassland associated with seasonally waterlogged clay soils and is sometimes also found on shallow, stony soils. In various parts of Africa, the plant is used for treatment of leprosy, cough and syphilis, snakebite, aphrodisiac, diarrhea, new and chronic wounds, malaria and even septic wounds and fungal infection of the scalp[7, 8]. Root, leaf and stem bark extracts of this plant have been investigated and established as having antifungal[9–11], antibacterial[11, 12] and antiproliferative properties. Stem bark of C. adenogonium have shown to exhibit significant Clostridium chauvoei neuraminidase enzyme inhibitory activity. Previous phytochemical analyses have shown that, extracts of stem barks, root and leaves of C. adenogonium contain flavonoids, tannins and few saponins[10, 14]. Furthermore, chemical analyses have shown that two phytosterols (β-sitosterol and stigmasterol) were isolated from the stem bark of C. adenogonium.
The current study investigated antibacterial, anti HIV-1 protease and cytotoxic activities of extracts of C. adenogonium as part of our continued efforts to explore biological activities of plants of the Combretaceae for possible development of phytodrug to be used in managing HIV and AIDS-related opportunistic infections.
Ethanol (absolute) was purchased from Fluka Chemie GmbH (Sigma-Aldrich®, Zwijndrecht, Netherlands), Dimethyl sulfoxide (DMSO) was from Sigma® (Poole, Dorset, UK) whereas Tryptone Soya agar and broth from HIMEDIA® (Himedia Laboratories Pvt Ltd, Mumbai, INDIA). Iodonitrotetrazolium chloride was bought from SIGMA® (Sigma- Aldrich®, St Louis, USA). 96 well microtitre plates supplied by KAS medics (Tanzania). Recombinant HIV-1 PR, substrate peptides and acetyl pepstatin were purchased from Sigma Chemical Co., St Louis (USA). Standard bacterial strains that were used for screening extracts were Escherichia coli (ATCC 25922), Pseudomonas aeruginosa (ATCC 29953), Salmonella typhi (NCTC 8385), Bacillus anthracis (NCTC 10073), Staphylococcus aureus (NCTC 25923), Klebsiella pneumoniae (NCTC 9633), Bacillus cereus (NCTC 7494) and two clinical isolates Streptococcus faecalis (clinical isolate) and Shigella flexneri (clinical isolate). All strains were obtained from the Department of Microbiology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
The Brine Shrimps eggs were purchased from Aquaculture innovations (Grahamstown 6140, South Africa) and sea salt was prepared locally by evaporating water collected from the Indian Ocean, along the Dar es Salaam coast.
Collection and extraction of plant materials
Roots, leaves and stem bark of C. adenogonium were collected from Handeni district, Tanga region, Tanzania. The plant was identified by Haji O. Seleman of the University of Dar es salaam, Botany Department. Herbarium specimen (voucher specimen collection number LBM 965) is deposited in the Herbarium of the Botany Department, University of Dar es Salaam. The collected plant material was air dried, pulverized and extracted with 80% aqueous ethanol at room temperature for 24hrs. The extracts were dried under vacuo followed by freeze-drying before analysis.
Determination of antibacterial activity
Antibacterial activity of extracts was determined against 9 strains of bacteria (4 Gram positive and 5 Gram negative) and their minimum inhibitory concentrations (MICs) were assayed through two fold microdilution method using sterile 96-well microtitre plates. Each well of the plates were first preloaded with 50 μl of the broth media followed by an addition of 50 μl of the extract (≤ 80mg/mL) into the first wells of each row tested. The resulting mixture were serially two fold diluted with tryptone soya broth media (made by dissolving 7.5g of tryptone soya broth in 250ml of sterilized distilled water) for each case 50 μl were drawn from the first row wells and transferred into the next and subsequent row wells. The remaining 50 μl from the last row well were discarded. Thereafter, 50 μl of the bacterial suspension (0.5 McFarland standard turbidity) was added in each well. Gentamycin sulphate was used as a positive control, DMSO as negative control while the rows with tryptone soya broth and bacteria only were used as growth controls. Both plates were incubated at 37°C for 24 h. MIC-values were determined by adding 20 μl of 0.02% p-iodonitrotetrazolium (INT) chloride dye in each well followed by incubation for 1 h at 37°C. The MIC-values of each extract was read at the concentration where a marked reduction in colour formation due to bacterial growth inhibition was noted.
Anti-HIV-1 protease inhibitory activity test
This assay was carried out according to previous report. In brief, the recombinant HIV-1 PR solution was diluted with a buffer composed of a solution containing 50mM of sodium acetate (pH 5.0), 1 mM ethylenediamine disodium (EDTA.2Na) and 2 mM 2-mercaptoethanol (2-ME) and mixed with glycerol in the ratio of 3:1. The substrate peptide, Arg-Val-Nle-(pNO2-Phe)-Glu-Ala-Nle-NH2, was diluted with a buffer solution of 50 mM sodium acetate (pH 5.0). 2μl of plant extract and 4 ml of HIV-1 PR solution (0.025 mg/ml) were added to a solution containing 2 ml of 50 mM buffer solution (pH 5.0) and 2 ml of substrate solution (2 mg/ml), and the reaction mixture (10 ml) was incubated at 37°C for 1 h. Acetyl pepstatin was used as a positive control and the reaction was performed under the same conditions. The reaction was stopped by heating the reaction mixture at 90oC for 1 min. Subsequently, 20 ml of sterilized water was added and an aliquot of 10 ml was analyzed by HPLC using RP-18 column (4.6 × 150 mm I.D., Supelco 516 C-18-DB 5 mm, USA). 10μl of the reaction mixture was injected to the column and gradiently eluted with acetonitrile (15-40%) and 0.2% trifluoroacetic acid (TFA) in water, at a flow rate of 1.0 ml/min. The elution profile was monitored at 280 nm. The retention times of the substrate and p-NO2-Phe-bearing hydrolysate were recorded at 11.25 and 9.72 min, respectively. The inhibitory activity on HIV-1 PR was calculated as follows:
Whereas A is a relative peak area of the product hydrolysate.
Brine shrimps lethality test
Brine shrimps lethality test (BST) was used to assay cytotoxicity activity of extracts. Briefly, stock solutions (40 mg/ml) of each plant extracts was prepared by dissolving them in dimethyl sulfoxide (DMSO). Different levels of concentrations (240, 120, 80, 40, 24 and 8 μg/ml) were prepared by drawing different volumes from the stock solutions and then added into vials, each containing ten brine shrimps larvae. The volume was adjusted to 5 ml with artificial sea water prepared by dissolving 3.8 g of sea salt in 1 L of distilled water. Each level of concentration was tested in duplicate. The negative control contained brine shrimps, artificial sea water and DMSO (0.6%) only. The vials were then incubated under light for 24 h. The dead larvae were counted and mean was subjected to analysis using Fig P computer program (Biosoft Inc, USA).
Phytochemical screening test
Test for tannins
About 1.0 g of the dried plant extract was boiled in 20 ml of water in a test tube and then filtered. A few drops of 0.1% ferric chloride was added and observed for brownish green or a blue-black colouration an indication of presence of tannins.
Test for saponins
About 2 g of the extract was boiled in 20 ml of distilled water in a water bath and filtered. 10 ml of the filtrate was mixed with 5 ml of distilled water and shaken vigorously for a stable persistent froth. The frothing was mixed with 3 drops of olive oil and shaken vigorously, then observed the formation of emulsion which indicates presence of saponins.
Test for flavonoids
Two methods were used to determine the presence of flavonoids in the plant extract. Dilute ammonia solution (5ml) were added to a portion of the aqueous filtrate of each extract followed by addition of concentrated H2SO4. A yellow colouration observed in each extract indicated the presence of flavonoids. The yellow colouration disappeared on standing.
A portion of the extract was in each case heated with 10 ml of ethyl acetate over a steam bath for 3 min. The mixture was filtered and 4 ml of the filtrate was shaken with 1 ml of dilute ammonia solution. A yellow colouration was observed indicating a positive test for flavonoids.
Test for terpenoids
5 ml of each extract was mixed in 2 ml of chloroform, and carefully 3 ml of concentrated H2SO4 was added to form a layer. A reddish brown colouration of the inter face was formed to show positive results for the presence of terpenoids.
Test for glycosides
0.5 gm of each sample was stirred with 10 ml of boiling distilled water. This was filtered and 2 ml of the filtrate hydrolyzed with few drops of concentrated HCl and the solution rendered alkaline with a few drops of ammonia solution. About 5 drops of this solution was added to 2 ml of benedict’s quantitative reagent and boiled. Appearance of reddish brown precipitate showed presence of glycosides.
The results of anti-HIV-1 PR activity were expressed as means ± SD of three determinations. The IC50 values were calculated using the Microsoft Excel programme with values greater than 100 μg/ml referred to as inactive for extracts. The mean results of brine shrimp mortality against the logarithms of concentrations were plotted using the Fig P computer program (Biosoft Inc, USA), which also gives regression equations. Regression equations were used to calculate LC16, LC50 and LC84 values. Confidence intervals (95% CI) were calculated according to a previously reported method. An LC50 value greater than 100 μg/ml was considered to represent an inactive extract. The MIC-values are interpreted as follows; 0.05-0.5 mg/ml - strong activity, 0.6-1.5 mg/ml - moderate activity and above 1.5 mg/ml - weak activity.
The antibacterial activity of aqueous ethanolic extracts from the root, stem bark and leaf of C. adenogonium are presented in Table1. All plant extracts showed activities to at least one of the test bacteria with MIC-values ranging from 0.31-5.0 mg/ml except for S. flexneri which was less susceptible (Table1). Moderate activity for stem bark extract was observed for B. cereus, P. aeruginosa and S. typhi each with MIC-value of 1.25 mg/ml. The root extract exhibited antibacterial activity against all the test organisms. Leaf extract was the most active against Gram-positive organisms namely B. cereus, B. anthracis and S. faecalis with MIC-values of 0.31, 0.31 and 0.63 mg/ml, respectively (Table1).
Anti-HIV-1 protease activity
Table2 shows results of the activity of root, stem bark and leaf extracts of C. adenogonium against HIV-1 protease inhibition activities. Root and stem bark extracts exhibited moderate activity with IC50 values of 24.7 and 26.5 μg/ml. Acetyl pepstatin was used as a positive control with an IC50 value of 2.2 μg/ml. Leaf extract was found to be inactive (IC50 > 100 μg/ml).
Brine shrimps test results
Results of the activity of stem bark, leaf and root extracts against brine shrimp larvae are shown in Table3. Leaf and stem bark extracts possessed mild toxicity to brine shrimps with LC50 values of 65.768 and 76.965 μg/ml, respectively. Leaf extract was non-toxic (LC50 = 110.042 μg/ml).
Phytochemical screening results
Results on preliminary phytochemical screening are shown in Table4. All extracts tested positive for presence of tannins. Flavonoids and saponins were detected to be present in both the root and leaf extracts whereas alkaloids were detected in stem bark only. While terpenoids were detected only in the leaf extract, glycosides were detected in root and stem bark extracts.
The antibacterial activity of aqueous ethanolic extracts from the root, stem bark and leaf of C. adenogonium was determined by screening extracts against standard bacterial strains and clinical isolates. All plant extracts showed activities to at least one of the test organism. Leaf extract was the most active against B. cereus, B. anthracis and S. faecalis with MIC-values of 0.31, 0.31 and 0.63 mg/ml, respectively, but had no activity against S. flexneri. The root extracts displayed antibacterial activity against all the test organisms. Similarly, stem bark extracts showed activity as the root extracts except for S. flexneri and S. faecalis in which there was no activity observed. These results corroborate well with previous investigations where records indicate that methanolic extracts of the root and the leaf of C. adenogonium showed activity against S. aureus. In the present study however, all the extracts showed activity against E.coli, contrary to what was previously reported that both the leaf and root extracts had no activity against E. coli. The differences however, might be contributed by the type of solvent that was used for extraction of plant components. In the present study, 80% aqueous ethanol was used as a solvent which might have extracted more polar constituents compared to methanolic extracts, which were used in the previous investigation. Antimicrobial results from the present and previous investigations[11, 12], lends support to further in vivo and other trials to validate the use of C. adenogonium in traditional medicine systems for treatment of diseases like diarrhea, coughs, syphilis, fresh wounds and septic wounds.
Aqueous ethanolic extracts of root and stem bark have exhibited moderate anti-HIV-1 protease inhibitory activity with IC50 value of 24.7 and 26.5 μg/ml, respectively, compared to Acetyl pepstatin which was used as a positive control with an IC50 value of 2.2 μg/ml (Table2). Leaf extract which was found to be inactive in this study, was previously reported to have anti-HIV-1 activity with an IC50 value of 2.7μg/ml. Thus, both root, leaf and stem bark extracts of C. adenogonium have anti-HIV properties, although mechanism of action or composition may be different. The anti-HIV-1 activity of C. adenogonium and its use in managing HIV/AIDS diseases is well supported by other species of Combretaceae[26–28]. The present study also showed that stem bark and leaf extracts exhibited some toxicity against brine shrimps while roots were virtually non-toxic (Table3). Our findings portrayed similar observations as previously reported for in vitro antiproliferative activity hence indicating this plant’s potential of being antiseptic and antitumor agent.
The present phytochemical screening results revealed presence of major classes of constituents including tannins, alkaloids, flavonoids, terpenoids, glycosides and saponins as presented in Table4. These classes of compounds are reported to exhibit a variety of biological activities including antiviral, antibacterial, anti-inflammatory and analgesic all of which are relevant to the traditional uses of this plant as claimed[29–31]. Presence of glycosides which were detected in the root and stem bark extracts only could be speculated as the major contributing factor for the anti-HIV-1 protease inhibitory activity in these extracts compared to other constituents for example, saponins and flavonoids that were detected in both the roots and leaves and tannins that were found in all the three extracts.
The antibacterial, anti-HIV-1 protease and cytotoxic activities exhibited by aqueous ethanolic extracts of C. adenogonium, lends support to further in vivo and other trials to validate the potential of this plant in the development of phytodrug for treatment of various ailments including HIV/AIDS-related opportunistic infections.
Iwu MM, Duncan AR, Okunji CO: New Antimicrobials of Plant Origin. Perspectives on newcrops and new uses. Edited by: Janick J. 1999, Alexandria, VA: ASHS Press
Masoko P, Picard J, Eloff JN: Antifungal activities of six South African Terminalia species (Combretaceae). J Ethnopharmacol. 2005, 99: 301-308. 10.1016/j.jep.2005.01.061.
Eloff JN, Katerere DR, McGaw LJ: The biological activity and chemistry of the southern African Combretaceae. J Ethnopharmacol. 2008, 119: 686-699. 10.1016/j.jep.2008.07.051.
Koudou J, Roblot G, Wylde R: Tannin Constituents of Terminalia glaucescens. Planta Med. 1995, 61: 490-491.
McGaw LJ, Rabe T, Sparg SG, Jager AK, Eloff JN, Van Staden J: An investigation on the biological activity of Combretum species. J Ethnopharmacol. 2001, 75 (1): 45-50. 10.1016/S0378-8741(00)00405-0.
Wickens GE: Combretaceae. Flora of Tropical East Africa. Edited by: Polhill RM. 1973, London: Crown Agents for Oversea Governments and Administrations
Maregesi SM, Ngassapa OD, Pieters L, Vlientinck AJ: Ethnopharmacological survey of the Bunda district, Tanzania: Plant used to treat infectious diseases. J Ethnopharmacol. 2007, 113: 457-470. 10.1016/j.jep.2007.07.006.
Fyhrquist P, Mwasumbi L, Vuorela P, Vuorela H, Hiltunen R, Murphy C, Adlercreutz H: Preliminary antiproliferative effects of some species of Terminalia, Combretum and Pteleopsis collected in Tanzania on some human cancer cell lines. Fitoterapia. 2006, 77: 358-366. 10.1016/j.fitote.2006.05.017.
Fyhrquist P, Mwasumbi L, Hæggström C-A, Vuorela H, Hiltunen R, Vuorela P: Antifungal Activity of Selected Species of Terminalia, Pteleopsis and Combretum (Combretaceae) Collected in Tanzania. Pharm Biol. 2004, 42 (4–5): 308-317.
Batawila K, Kokou K, Koumaglo K, Gbe'assor M, Foucault D, Bouchet P, Akpagana K: Antifungal activities of five Combretaceae used in Togolese traditional medicine. Fitoterapia. 2005, 76: 264-268. 10.1016/j.fitote.2004.12.007.
Maregesi SM, Pieters L, Ngassapa OD, Apers S, Vingerhoets R, Cos P, Vanden Berghe DA, Vlietinck AJ: Screening of some Tanzanian medicinal plants from Bunda district for antibacterial, antifungal and antiviral activities. J Ethnopharmacol. 2008, 119: 58-66. 10.1016/j.jep.2008.05.033.
Fyhrquist P, Mwasumbi L, Hæggström C-A, Vuorela H, Hiltunen R, Vuorela P: Ethnobotanical and antimicrobial investigation of some species of Terminalia and Combretum (Combretaceae) growing in Tanzania. J Ethnopharmacol. 2002, 79: 169-177. 10.1016/S0378-8741(01)00375-0.
Useh NM, Nok AJ, Ambali SF, Esievo KAN: The Inhibition of Clostridium chauvoei (Jakari strain) Neurarninidase Activity by Methanolic Extracts of the Stem Barks of Tamarindus indicus and Combretum fragrans. Journa1 of Enzyme Inhibition and Medicinal Chemistry. 2004, 19 (4): 339-342. 10.1080/14756360409162447.
Chhabra SC, Uiso FC: A survey of the medicinal plants of Eastern Tanzania for Alkaloids, flavonoids, saponins and tannins. Fitoterapia. 1990, 61: 4-
Maima AO, Thoithi GN, Ndwigah SN, Kamau FN, Kibwage IO: Phytosterols from the stem bark of Combretum fragrans F. Hoffm. East and Central African Journal of Pharmaceutical Sciences. 2008, 11: 52-55.
Eloff JN: A sensitive and quick microplate method to determine the minimal inhibitory concentration of plant extracts for bacteria. Planta Med. 1998, 64: 711-713. 10.1055/s-2006-957563.
Tewtrakul S, Subhadhirasakul S, Kummee S: HIV-1 protease inhibitory effects of medicinal plants used as self medication by AIDS patients. Songklanakarin Journal of Science and Technology. 2003, 25: 239-243.
Meyer BN, Ferrign RN, Putnam JE, Jacobson LB, Nicholas DE, McLaughlin JL: Brine Shrimp: a convenient general bioassay for active plant constituents. Planta Med. 1982, 45: 31-34. 10.1055/s-2007-971236.
Trease GE, Evans WC: A text book of Pharmacognosy. 1989, London: Bailliere Tindall Ltd, ISBN 0702013617, 13
Harborne JB: Phytochemical methods. 1973, Chapman and Hall, Ltd: London, 49-188.
Litchfield JR, Wilcoxon F: A Simplified Method of Evaluating Dose-Effect Experiments. J Pharmacol and Exp Therap. 1949, 96: 99-138.
Moshi MJ, Innocent E, Magadula JJ, Otieno DF, Weisheit A, Mbabazi PK, Nondo RSO: Brine shrimps toxicity of some plants used as traditional medicines in Kagera region, north western Tanzania. Tanzan J Health Res. 2010, 12: 1-
Sartoratto A, Machado ALM, Delarmelina C, Figueira GM, Duarte MCT, Rehder VLG: Composition and antimicrobial activity of essential oils from aromatic plants used in Brazil. Braz J Microbiol. 2004, 35: 275-280. 10.1590/S1517-83822004000300001.
Kokwaro JO: Medicinal Plants of East Africa. 1976, Kampala, Nairobi, Dar es Salaam: East African Literature Bureau, 55-
Inngjerdingen K, Nergard CS, Diallo D, Mounkoro PP, Paulsen BS: An ethnopharmacological survey of plants used for wound healing in Dogonland, Mali, West Africa. J Ethnopharmacol. 2004, 92: 233-244. 10.1016/j.jep.2004.02.021.
Maregesi S, Van Miert S, Pannecouque C, Feiz Haddad MH, Hermans N, Wright CW, Vlietinck AJ, Apers S, Pieters L: Screening of Tanzanian medicinal plants against Plasmodium Faliciparum and Human immunodeficiency virus. Planta Med. 2009, 75: 1-7.
Tewtrakul S, Miyashiro H, Nakamura N, Hattori M, Kawahata T, Otake T, Yoshinaga T, Fujiwara T, Supavita T, Yuenyongsawad S, Rattanasuwon P, Dej-Adisai S: HIV-1 intergrase inhibitory substances from Coleus parvifolius. Phytother Res. 2003, 17: 232-239. 10.1002/ptr.1111.
Kisangau DP, Lyaruu HVM, Hosea KM, Joseph CC: Use of traditional medicines in the management of HIV/AIDS opportunistic infections in Tanzania: a case in the Bukoba rural district. J Ethnobiol Ethnomed. 2007, 3: 29-10.1186/1746-4269-3-29.
Tsuchiya H, Sato M, Miyazaki T, Fujiwara S, Tanigaki S, Ohyama M, Tanaka T, Iinuma M: Comparative study on the antibacterial activity of phytochemical flavanones against methicillin-resistant Staphylococcus aureus. J Ethnopharmacol. 1996, 50: 27-34. 10.1016/0378-8741(96)85514-0.
Kolodziej H, Kayser O, Latte KP, Ferreira D: Evaluation of the antimicrobial potency of tannins and related compounds using the microdilution broth method. Planta Med. 1999, 65: 444-446. 10.1055/s-2006-960806.
Ojewole JAO: Analgesic and Antiinflammatory Effects of Mollic Acid Glucoside, a 1α-Hydroxycycloartenoid Saponin Extractive from Combretum molle R. Br. ex G. Don (Combretaceae) Leaf. Phytother Res. 2008, 22: 30-35. 10.1002/ptr.2253.
The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6882/12/163/prepub
This project was supported by grant from Ministry of Health and Social Welfare, Tanzania, under MUHAS postgraduate research programme. We are grateful to Mr. Haji O. Selemani for collection and identification of the plant.
The authors declare that they have no competing interests.
NFM conceptualized the study, developed study protocol, contributed to data acquisition and analysis, and preparation of the manuscript. ZHM supervised the study and preparation of the manuscript. EI developed study protocol, contributed to data analysis and preparation of the manuscript. ST performed the HIV-1 protease assay and analysis of data. All authors read and approved the final manuscript.
About this article
Cite this article
Mushi, N.F., Mbwambo, Z.H., Innocent, E. et al. Antibacterial, anti-HIV-1 protease and cytotoxic activities of aqueous ethanolic extracts from Combretum adenogonium Steud. Ex A. Rich (Combretaceae). BMC Complement Altern Med 12, 163 (2012) doi:10.1186/1472-6882-12-163
- Combretum adenogonium
- Anti-HIV-1 protease